Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H12N4O4S |
InChIKeyVHZNRMYBOZEULM-FMQUCBEESA-N |
CAS Registry2914127-30-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JO | 01 Mar 2022 |